[HTML][HTML] Drug resistance and combating drug resistance in cancer
Cancer is the second leading cause of death in the US. Current major treatments for cancer
management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy …
management include surgery, cytotoxic chemotherapy, targeted therapy, radiation therapy …
Cancer stem cell (CSC) resistance drivers
M Najafi, K Mortezaee, J Majidpoor - Life sciences, 2019 - Elsevier
Cancer stem cells (CSCs) are a population of self-renewal cells with high tumorigenic
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
potency. CSCs can adopt easily with changes in the nearby milieu, and are more resistant to …
Through scalp and skull NIR‐II photothermal therapy of deep orthotopic brain tumors with precise photoacoustic imaging guidance
Brain tumor is one of the most lethal cancers owing to the existence of blood–brain barrier
and blood–brain tumor barrier as well as the lack of highly effective brain tumor treatment …
and blood–brain tumor barrier as well as the lack of highly effective brain tumor treatment …
[HTML][HTML] 3D Bioprinted cancer models: Revolutionizing personalized cancer therapy
After cardiovascular disease, cancer is the leading cause of death worldwide with
devastating health and economic consequences, particularly in developing countries. Inter …
devastating health and economic consequences, particularly in developing countries. Inter …
Role of glioblastoma stem cells in cancer therapeutic resistance: A perspective on antineoplastic agents from natural sources and chemical derivatives
ALV Alves, INF Gomes, AC Carloni, MN Rosa… - Stem Cell Research & …, 2021 - Springer
Glioblastoma (GBM) is the highest-grade form of glioma, as well as one of the most
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …
aggressive types of cancer, exhibiting rapid cellular growth and highly invasive behavior …
Pathological and molecular features of glioblastoma and its peritumoral tissue
A D'Alessio, G Proietti, G Sica, BM Scicchitano - Cancers, 2019 - mdpi.com
Glioblastoma (GBM) is one of the most aggressive and lethal human brain tumors. At
present, GBMs are divided in primary and secondary on the basis of the mutational status of …
present, GBMs are divided in primary and secondary on the basis of the mutational status of …
Cancer stem cells: significance in origin, pathogenesis and treatment of glioblastoma
K Biserova, A Jakovlevs, R Uljanovs, I Strumfa - Cells, 2021 - mdpi.com
Cancer stem cells (CSCs), known also as tumor-initiating cells, are quiescent, pluripotent,
self-renewing neoplastic cells that were first identified in hematologic tumors and soon after …
self-renewing neoplastic cells that were first identified in hematologic tumors and soon after …
Glioblastoma: current status, emerging targets, and recent advances
Glioblastoma (GBM) is a highly malignant brain tumor characterized by a heterogeneous
population of genetically unstable and highly infiltrative cells that are resistant to …
population of genetically unstable and highly infiltrative cells that are resistant to …
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Glioblastoma is a highly angiogenetic malignancy, the neoformed vessels of which are
thought to arise by sprouting of pre-existing brain capillaries. The recent demonstration that …
thought to arise by sprouting of pre-existing brain capillaries. The recent demonstration that …
Mitochondrial control by DRP1 in brain tumor initiating cells
Brain tumor initiating cells (BTICs) co-opt the neuronal high affinity glucose transporter,
GLUT3, to withstand metabolic stress. We investigated another mechanism critical to brain …
GLUT3, to withstand metabolic stress. We investigated another mechanism critical to brain …